PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK; University of Birmingham, Birmingham, UK; University Hospitals Birmingham, Birmingham, UK. Electronic address: l.lee.2@bham.ac.uk.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK; University of Birmingham, Birmingham, UK.\', \'The Royal Marsden Hospital NHS Foundation Trust, London, UK.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.\', \'Centre for Computational Biology, University of Birmingham, Birmingham, UK; University of Birmingham, Birmingham, UK.\', \'Institute of Translational Medicine, Birmingham Health Partners, Birmingham, UK.\', \'Cancer Research Clinical Research Facility, St George\'s University Hospitals NHS Foundation Trust, London, UK.\', \'Leeds Institute of Medical Research, University of Leeds, Leeds, UK.\', \'Glasgow Royal Infirmary, Glasgow, UK.\', \'Centre for Computational Biology, University of Birmingham, Birmingham, UK; Advanced Research Computing, University of Birmingham, Birmingham, UK.\', \'Department of Cancer Imaging, King\'s College London, London, UK.\', \'Nuffield Division of Clinical and Laboratory Services, Oxford University, Oxford, UK.\', \'UCL Cancer Institute, University College London, London, UK.\', \'University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK.\', \'St George\'s University Hospitals NHS Foundation Trust, London, UK.\', \'Department of Oncology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.\', \'The Clatterbridge Cancer Centre, Wirral, UK.\', \'St George\'s University of London, London, UK.\', \'Bart\'s Cancer Institute, London, UK.\', \'University of Birmingham Medical School, University of Birmingham, Birmingham, UK.\', \'Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.\', \'Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.\', \'Department of Oncology, Oxford University, Oxford, UK.\', \'Consultancy Support, Oxford, UK.\', \'Nuffield Department of Medicine, Oxford University, Oxford, UK.\', \'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; University Hospitals Birmingham, Birmingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(20)31173-910.1016/S0140-6736(20)31173-9
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32473682
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all